Three Japanese pharmas and AstraZeneca in 'booster' plan for neglected diseases
This article was originally published in Scrip
Executive Summary
The Drugs for Neglected Diseases initiative (DNDi) and four pharmaceutical firms – Eisai, Shionogi, Takeda and AstraZeneca – are collaborating on a new project to find therapies for two of the world's most neglected diseases: leishmaniasis and Chagas disease.